Rickard Jason 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Aug 10, 2022
Insider Transaction Report
Form 4
Rickard Jason
SVP, Chief Operating Officer
Transactions
- Sale
Class A Common Stock
2022-08-08$11.64/sh−27,200$316,608→ 378,966 total - Exercise/Conversion
Class A Common Stock
2022-08-09$11.65/sh+18,041$210,178→ 394,771 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2022-08-09−18,041→ 0 totalExercise: $11.65Exp: 2023-02-01→ Class A Common Stock (18,041 underlying) - Sale
Class A Common Stock
2022-08-08$11.56/sh−2,236$25,848→ 376,730 total - Sale
Class A Common Stock
2022-08-09$11.75/sh−18,041$211,982→ 376,730 total
Footnotes (4)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.63 to $11.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The reporting person acquired 2,092 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2022.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.74 to $11.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]This option, granted as an annual performance award, is presently exercisable in full.